Header Logo

Connection

Anne-Marie Malfait to Alkynes

This is a "connection" page, showing publications Anne-Marie Malfait has written about Alkynes.
Connection Strength

0.019
  1. Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing. Antimicrob Agents Chemother. 2007 Oct; 51(10):3554-61.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.